Ohio Public Employees Retirement System (OPERS)’s Entrada Therapeutics TRDA Stock Holding History
Bought
Maintained
Sold
Other funds holding TRDA
BBA
5VM
MC
MB
SG
Ohio Public Employees Retirement System (OPERS)'s TRDA Position: Q2 2026 in Review
Ohio Public Employees Retirement System (OPERS) held its Entrada Therapeutics (TRDA) position steady in Q2 2026 at 37,502 shares worth $276K. The position accounts for ﹤0.01% of the portfolio, ranked #1600.
Ohio Public Employees Retirement System (OPERS) first reported a position in TRDA in Q2 2024 and has held it in 9 quarters since. The position peaked at $473K in Q1 2026. 128 funds tracked by Wall St. Rank hold TRDA as of Q2 2026.
- Ohio Public Employees Retirement System (OPERS) held 37,502 shares of Entrada Therapeutics worth $276K as of Q2 2026.
- Ohio Public Employees Retirement System (OPERS) left its Entrada Therapeutics share count unchanged in Q2 2026.
- Entrada Therapeutics made up ﹤0.01% of Ohio Public Employees Retirement System (OPERS)'s portfolio in Q2 2026, its #1600 holding.
- Ohio Public Employees Retirement System (OPERS) first reported a position in Entrada Therapeutics in Q2 2024 and has held it in 9 quarters since.
- Ohio Public Employees Retirement System (OPERS)'s Entrada Therapeutics position peaked at $473K in Q1 2026.
- 128 funds tracked by Wall St. Rank held Entrada Therapeutics as of Q2 2026.
Based on Ohio Public Employees Retirement System (OPERS)'s 13F filing for Q2 2026, filed 17 Aug 2026.